Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

NIH awards research grant for development of Cel-Sci's AIDS vaccine

Oct. 30, 1997

Procept completes phase I testing with PRO-2000 gel

Oct. 22, 1997

Aronex receives grants for development of HIV integrase inhibitor

Oct. 22, 1997

Positive results obtained with Theratechnologies' AIDS gene therapy

Oct. 21, 1997

Promising preliminary phase II data reported for VX-478/141W94

Oct. 20, 1997

HIV-infected T-cells and macrophages efficiently killed by new T-cell gene therapy

Oct. 16, 1997

PNU-140690: a novel HIV protease inhibitor in clinical testing at P&U

Oct. 14, 1997

Combined pharmacological/genetic strategy for HIV shows promise

Oct. 13, 1997

NIH approves study of marijuana in HIV-infected patients

Oct. 13, 1997

Boehringer Ingelheim presents compounds active against mutant HIV-1 RT

Oct. 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...